Bleichmar Fonti & Auld LLP | Complex Litigation Law Firm | Dominic Auld Appears on Business News Network to Discuss Valeant Pharmaceuticals
This links to the home page
News

Dominic Auld Appears on Business News Network to Discuss Valeant Pharmaceuticals

October 29, 2015
BFTA founding partner Dominic Auld appeared on Business News Network’s “The Close” to discuss the significant news regarding Canadian issuer Valeant Pharmaceuticals – which saw shares lose over half their value since the release of a series of damaging reports beginning on October 19, 2015.  Valeant is a multinational specialty drug company, facing scrutiny over allegations of price gauging and the recording of false drug sales through affiliated pharmacies.  During the interview, Mr. Auld discussed the pharmaceutical firm’s lack of transparency and the potential legal implications Valeant may face in several jurisdictions.  Click below for the full interview:

Link to Dominic Auld Interview